Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (16.667%)
Market Cap: £1.03m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Appointment of Director

30 Sep 2015 18:16

RNS Number : 8283A
Sabien Technology Group PLC
30 September 2015
 



Sabien Technology Group plc ('Sabien' or the 'Company')

Appointment of Non-Executive Director

Sabien is pleased to announce the appointment of Mr Bruce Gordon as a non-executive Director. As set out in the announcement of 20 July 2015, it is the Company's longer term intention to appointment Mr Bruce Gordon as Chairman. This will be reviewed over the coming months and an appropriate announcement made of any changes.

Bruce, 55, is the founder of Thames Valley Capital Limited, a venture capital and private equity firm that specialises in early stage, seed investments, growth capital and bridge loans. Until 2008, Bruce was a senior audit partner with Deloitte & Touche LLP and was a member of the Board of Partners and the partner in charge of the southern region. Prior to Deloitte, Bruce was a partner in Arthur Andersen, where he managed the UK regional practice. Until 2011 Bruce was Honorary Treasurer for the Guide Dogs for the Blind Association, one of the largest charities in the UK. He is also Chairman, and a founder, of the Honorary Treasurers Forum, a charity that promotes governance and education for Honorary Treasurers, and Honorary Treasurer of the National Council for Voluntary Organisations.

Commenting on the appointment, Mr Alan O'Brien, Chief Executive of Sabien said:

'I am delighted to welcome Bruce to the Board as a director. Bruce has been an investor in Sabien since July 2009 and firmly believes in the Company's new strategy of delivering free pilots to its pipeline of potential customers in order to scale up the number of pilot projects delivered and increase the predictability of contract award and start dates. Bruce has shown this commitment to the new strategy through his direct and indirect (through TVI 2 Limited) participation in the recent placing. I have no doubt that Bruce's skills will be invaluable in rolling the strategy out and ensuring that the Company delivers on it.'

Save for the disclosures above and below, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

Current Directorships

 

Past Directorships

Thames Valley Capital

 

Deloitte LLP

Cornerstone Private Equity LLP

 

Knights LLP

GDBA Pension Fund Trustee

 

Guide Dogs for the Blind

National Council for Voluntary Organisations

 

 

NCVO Trading

 

 

TVC1

 

 

TVI 1

 

 

TVC 2

 

 

TVC 3

 

 

TVC 4

 

 

Bruce holds 1,650,000 ordinary shares in the Company directly, representing 3.73% of the issued share capital. Bruce is also a director of Thames Valley Capital Limited, an advisor to TVI 2 Limited, which holds 4,108,356 ordinary shares in the Company, representing 9.34% of the issued share capital. Bruce is therefore interested, directly and indirectly, in 5,768,356 ordinary shares, representing 13.07% of the issued share capital.

For further information:

Sabien Technology Group plc

 

Alan O'Brien, Chief Executive

Tel: +44(0) 207 993 3700

Gus Orchard, Finance Director

 

 

 

Westhouse Securities Ltd

 

Antonio Bossi

Tel: +44(0) 20 7601 6100

Rose Ramsden

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALMMRTMBMJBIA
Date   Source Headline
11th Jun 20267:00 amRNSIssue of shares to directors & broker
2nd Jun 20267:00 amRNSProposed balance sheet strengthening & M2G update
29th May 20265:00 pmRNSTotal Voting Rights
21st May 20267:00 amRNSProposed Commercial Partnership & Investment
20th May 20266:22 pmRNSSettlement of Historical Contract
31st Mar 20267:00 amRNSHalf-year Report for the 6 months to 31 Dec 2025
10th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Jan 20265:30 pmRNSHolding(s) in Company
22nd Dec 202512:02 pmRNSUpdate on Funding and Strategic Arrangements
22nd Dec 202512:02 pmRNSUpdate on Funding and Strategic Arrangements
9th Dec 20251:20 pmRNSResult of Annual General Meeting
9th Dec 20257:00 amRNSAGM Statement & Trading Update
19th Nov 20257:00 amRNSProposed Strategic Agreement with COF
13th Nov 20257:00 amRNSFinal Results for the Year Ended 30 June 2025
10th Nov 20257:00 amRNSNew Factoring Facility
5th Nov 202512:01 pmRNSAppointment of Corporate Broker
2nd Oct 202512:06 pmRNSFurther update on Sabien, b.grn & related matters
19th Sep 20257:00 amRNSTrading Update
31st Jul 20254:59 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSYear End Trading Update
30th Jun 20252:53 pmRNSIssue of shares to directors
23rd Jun 20254:28 pmRNSHolding(s) in Company
17th Mar 20257:00 amRNSHalf-year Report for the 6 months to 31 Dec 2024
6th Feb 202511:43 amRNSUpdate in relation to Aeristech Limited
27th Jan 20257:00 amRNSTrading update - acceleration of new M2G orders
31st Dec 202412:30 pmRNSTotal Voting Rights
19th Dec 202410:51 amRNSResult of Annual General Meeting
19th Dec 20247:00 amRNSUpdate on US Waste Plastics to Oil Project
28th Nov 20247:00 amRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSIssue of shares to non-executive directors
18th Nov 20247:00 amRNSFinal Results & Annual Report & Accounts for 2024
11th Nov 20247:00 amRNSNew M2G Cloud Connection System Order
17th Oct 20247:00 amRNSUpdate on US Waste Plastics to Oil Project
30th Sep 20245:00 pmRNSTotal Voting Rights
26th Sep 20244:21 pmRNSDirector/PDMR Shareholding
19th Sep 20241:00 pmRNSHolding(s) in Company
4th Sep 20245:30 pmRNSAdmission of New Shares & Total Voting Rights
29th Aug 20244:00 pmRNSUpdate on Admission of New Ordinary Shares
20th Aug 20247:00 amRNSRelated Party Funding
8th Jul 20248:15 amRNSTrading Statement
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 202411:52 amRNSHolding(s) in Company
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 202411:27 amRNSResult of Broker Option, Issue of Equity and TVR
20th Feb 20243:45 pmRNSDirector/PDMR Shareholding
19th Feb 20247:45 amRNSPlacement and Broker Option
19th Feb 20247:30 amRNSHalf-year Report for the 6 months to 31 Dec 2023
7th Feb 20247:00 amRNSNew system installed at Hampton Court Palace

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.